106 related articles for article (PubMed ID: 22000524)
1. Correlative magnetic resonance imaging and autopsy findings in a patient with coagulation necrosis treated with tissue plasminogen activator.
Suzuki M; Uchihara T; Toru S; Bae Y; Igari T; Kitagawa M; Uchiyama S; Hirokawa K; Kobayashi T
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):512-4. PubMed ID: 22000524
[TBL] [Abstract][Full Text] [Related]
2. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke.
Tanaka K; Ohara T; Ishigami A; Ikeda Y; Matsushige T; Satow T; Ishibashi-Ueda H; Iihara K; Toyoda K
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):395-7. PubMed ID: 23545321
[TBL] [Abstract][Full Text] [Related]
3. Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.
Alonso A; Dempfle CE; Szabo K; Zohsel K; Hennerici MG
Thromb Res; 2011 Jan; 127(1):65-6. PubMed ID: 20537372
[No Abstract] [Full Text] [Related]
4. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
Parsons MW
Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
[No Abstract] [Full Text] [Related]
5. Thrombolytic therapy in patients with submassive pulmonary embolism.
Dalen JE
N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542064
[No Abstract] [Full Text] [Related]
6. Cardiac papillary fibroelastoma: source of cerebral embolism treated with intravenous thrombolysis.
Matijević V; Poljaković Z; Ilić I; Cikeš I; Habek M
J Stroke Cerebrovasc Dis; 2011; 20(5):485-7. PubMed ID: 20692856
[TBL] [Abstract][Full Text] [Related]
7. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
Shobha N; Buchan AM; Hill MD;
Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
[TBL] [Abstract][Full Text] [Related]
9. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K
Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188
[TBL] [Abstract][Full Text] [Related]
10. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
Mooney T; Joseph P
Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
[No Abstract] [Full Text] [Related]
11. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E
Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985
[No Abstract] [Full Text] [Related]
12. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
[No Abstract] [Full Text] [Related]
13. Intravenous thrombolysis is unsafe in stroke due to infective endocarditis.
Brownlee WJ; Anderson NE; Barber PA
Intern Med J; 2014 Feb; 44(2):195-7. PubMed ID: 24528816
[TBL] [Abstract][Full Text] [Related]
14. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
[TBL] [Abstract][Full Text] [Related]
15. [Superselective fibrinolysis for a middle cerebral artery embolism caused by a left atrial myxoma: case report].
Yamanome T; Yoshida K; Miura K; Ogawa A
No Shinkei Geka; 2000 Jul; 28(7):653-8. PubMed ID: 10920828
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke.
Matrat A; De Mazancourt P; Derex L; Nighoghossian N; Ffrench P; Rousson R; Hanss M
Thromb Res; 2013 Jan; 131(1):e45-8. PubMed ID: 23199548
[No Abstract] [Full Text] [Related]
17. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
[TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
[TBL] [Abstract][Full Text] [Related]
19. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
20. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
